Navigation Links
Chesley Files Lawsuits on Behalf of Ohio Residents Who Lost Sense of Smell After Taking Zicam
Date:2/4/2010

CINCINNATI, Feb. 4 /PRNewswire/ -- Stanley M. Chesley from the Cincinnati, Ohio-based law firm of Waite, Schneider, Bayless & Chesley Co., L.P.A. today filed a lawsuit on behalf of two Cincinnati women who have experienced loss of smell and taste after using Zicam Cold Remedy Nasal Gel.  Zicam is an over-the-counter cold and flu remedy manufactured by Matrixx Initiatives and voluntarily recalled in June of 2009.

The lawsuit was filed in the Hamilton County Court of Common Pleas in Cincinnati, Ohio. It alleges negligence, defect in design and manufacture, failure to warn, breach of warranties, fraudulent concealment, and state consumer laws.  For years Matrixx knew of complaints of loss of smell (known as anosmia) from users of the recalled Zicam product, but failed to alert consumers.  On June 16, 2009, the FDA issued a warning advising consumers to "stop using and discard" three Zicam products, including Zicam Cold Remedy Nasal Gel, because Zicam is "associated with the loss of sense of smell."  Following the warning issued by the FDA, the company voluntarily recalled the nasal gel as well as several other Zicam products.  

Waite, Schneider, Bayless & Chesley is continuing to investigate incidents involving Zicam use.

For more than 40 years, Stanley M. Chesley and Waite, Schneider, Bayless & Chesley Co., L.P.A. has represented individuals from across the United States in a variety of personal injury, breach of contract, fraud, and negligence claims, including complex product liability cases, toxic exposure, and dangerous prescription drugs.  More on information on the firm is found at http://www.wsbclaw.com

CONTACT: Stanley M. Chesley, Robert A. Steinberg, or Renee A. Infante at (513) 621-0267

SOURCE Waite, Schneider, Bayless & Chesley Co. LPA

RELATED LINKS
http://www.wsbclaw.com

'/>"/>

SOURCE Waite, Schneider, Bayless & Chesley Co. LPA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Justice Department Files for Immediate Relief Regarding Conditions in Georgias Hospitals
2. Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research
3. Alex & Gaxiola Legal Team Files Bold Motions to Disqualify Maricopa County Attorney's Office in Criminal Cases Pending in Superior Court
4. Americans United for Life Files Brief Detailing Abortions Suicide Risk
5. Organogenesis Files PMA for CelTx(TM) for Oral Soft Tissue Regeneration
6. Tyco International Files Preliminary Proxy Proposing Election of New Director
7. Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering
8. Haemonetics Files a New Legal Action to Stop Fenwal Inc.s Continued Patent Infringement
9. BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment
10. Patient Files Suit Against St. Vincents Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure
11. Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: